104 related articles for article (PubMed ID: 16828466)
1. CTLA-4.FasL inhibits allogeneic responses in vivo.
Dranitzki-Elhalel M; Huang JH; Rachmilewitz J; Pappo O; Parnas M; Schmidt W; Tykocinski ML
Cell Immunol; 2006 Feb; 239(2):129-35. PubMed ID: 16828466
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4. FasL induces alloantigen-specific hyporesponsiveness.
Elhalel MD; Huang JH; Schmidt W; Rachmilewitz J; Tykocinski ML
J Immunol; 2003 Jun; 170(12):5842-50. PubMed ID: 12794109
[TBL] [Abstract][Full Text] [Related]
3. In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro.
Hsu LJ; Jan MS; Lin YS
Cell Immunol; 2000 Apr; 201(1):50-7. PubMed ID: 10805973
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells.
Huang JH; Tykocinski ML
Int Immunol; 2001 Apr; 13(4):529-39. PubMed ID: 11282992
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
Georgantas RW; Bohana-Kashtan O; Civin CI
Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
7. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
Modiano JF; Sun J; Lang J; Vacano G; Patterson D; Chan D; Franzusoff A; Gianani R; Meech SJ; Duke R; Bellgrau D
Clin Immunol; 2004 Jul; 112(1):54-65. PubMed ID: 15207782
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
9. Listeria monocytogenes virulence proteins induce surface expression of Fas ligand on T lymphocytes.
Zenewicz LA; Skinner JA; Goldfine H; Shen H
Mol Microbiol; 2004 Mar; 51(5):1483-92. PubMed ID: 14982640
[TBL] [Abstract][Full Text] [Related]
10. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
11. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
12. [Selected elimination of mouse alloreactive T cells by Fas-FasL passway].
Liu L; Zou P; Xu Z; Hu Z; Chen Y; Song S
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):187-90. PubMed ID: 12133454
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.
Razmara M; Hilliard B; Ziarani AK; Chen YH; Tykocinski ML
Int Immunol; 2008 Apr; 20(4):471-83. PubMed ID: 18272926
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 . FasL induces early apoptosis of activated T cells by interfering with anti-apoptotic signals.
Orbach A; Rachmilewitz J; Parnas M; Huang JH; Tykocinski ML; Dranitzki-Elhalel M
J Immunol; 2007 Dec; 179(11):7287-94. PubMed ID: 18025171
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the cell-mediated immune response by a Fas-immunoglobulin fusion protein.
Shen Y; Young B; Lipman ML
Transplantation; 2006 Apr; 81(7):1041-8. PubMed ID: 16612282
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin.
Jin Y; Qu A; Wang GM; Hao J; Gao X; Xie S
Gene Ther; 2004 Jun; 11(12):982-91. PubMed ID: 15042121
[TBL] [Abstract][Full Text] [Related]
19. Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45beta.
Wang L; Du F; Cao Q; Sheng H; Shen B; Zhang Y; Diao Y; Zhang J; Li N
Cell Res; 2006 Aug; 16(8):702-12. PubMed ID: 16826163
[TBL] [Abstract][Full Text] [Related]
20. B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo.
Kosiewicz MM; Krishnan A; Worthington MT; Matriano JA; Ross WG
Eur J Immunol; 2002 Jun; 32(6):1679-87. PubMed ID: 12115651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
